Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlycoMimetics Inc (NASDAQ:GLYC)

6.36
Delayed Data
As of Feb 24
 +0.07 / +1.11%
Today’s Change
4.28
Today|||52-Week Range
9.25
+4.26%
Year-to-Date
No recent news for GlycoMimetics Inc.

Today’s Trading

Previous close6.29
Today’s open6.18
Day’s range6.17 - 6.64
Volume82,785
Average volume (3 months)46,565
Market cap$146.7M
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-11.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+33.56%
P/E ratioNM
Price/Sales5.42
Price/Book2.99

Competitors

 Today’s
change
Today’s
% change
VTLVital Therapies Inc0.000.00%
OCXOncoCyte Corp+0.17+3.39%
ABUSArbutus Biopharma Co...0.000.00%
FBIOFortress Biotech Inc-0.02-0.68%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$20.1M
Annual profit (last year)-$12.8M
Net profit margin-63.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Rachel K. King
Chief Financial Officer
Brian M. Hahn
Corporate headquarters
Rockville, Maryland

Forecasts


Search for Jobs